Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.32 |
| ▸ | MME | P08473 | 2/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CETP | P11597 | 1/20 | 0.30 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7365053 | 0.98 | CYP2C19 (0.47) | CYP2C19MMEFFAR3 | |
| SCHEMBL6639985 | 0.81 | CYP2C19 (0.31) | CYP2C19ALDH1A1 | |
| SCHEMBL4814568 | 0.79 | — | — | |
| SCHEMBL8278870 | 0.79 | CYP2C19 (0.54) | CYP2C19TBXAS1MMEUSP2ALDH1A1 | |
| SCHEMBL6876483 | 0.74 | CYP2C19 (0.48) | CYP2C19TBXAS1MMEALDH1A1 | |
| SCHEMBL7364717 | 0.73 | CYP4F2 (0.38) | — | |
| SCHEMBL11383971 | 0.72 | CYP2C19 (0.68) | CYP2C19TBXAS1MMEUSP2ALDH1A1 | |
| SCHEMBL9640977 | 0.72 | CYP2C19 (0.60) | CYP2C19TBXAS1MMEUSP2ALDH1A1 | |
| SCHEMBL30186714 | 0.72 | CYP2C19 (0.60) | CYP2C19TBXAS1MMEUSP2ALDH1A1 | |
| SCHEMBL265530 | 0.72 | CYP2C19 (0.60) | CYP2C19TBXAS1MMEUSP2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008124148-A2 | SULFUR COMPOUNDS AS INHIIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE | SCHERING CORPORATION (US) | 2008-10-16 | — | — | WO | disclosed |
| EP-0640594-A1 | Hydantoin derivative as metalloprotease inhibitor | FUJIREBIO INC. (JP) | 1995-03-01 | — | — | EP | disclosed |